The Oncolinx team has been working hard securing funding to move forward with the NCI technology. Oncolinx was accepted into the MassChallenge Accelerator, the largest accelerator in the world. Oncolinx was 1 out of 127 total teams admitted from a pool of 1700+ startups that applied from 40 US states and 51 countries around the world. In late June, Oncolinx relocated to the scenic Seaport district of Boston to participate in this accelerator that offers world-class mentorship, exposure, funding opportunities, in-kind services totaling more than $10MM, and cash prizes of more than $1MM. So far, Oncolinx has been arranged law services with the lawyers at top-tier law firm Foley & Lardner, LLP. Oncolinx has also secured renowned advisors and mentors with drug development, investor, bio-entrepreneurial experience. Many of these mentors have successfully founded and exited their own biotechs. Now operating in the Heart of Boston, Oncolinx has had the opportunity to engage Boston’s diverse Angel and VC groups. Recently, Oncolinx was also named a Semi-Finalist in the LiveStrong Big C Competition and the winner of the Global Biotech Revolution (GBR) – Voices of Tomorrow Competition. As winner of the GBR Voices of Tomorrow Competition, Oncolinx was awarded £2,000. In addition, Oncolinx was given mentorship by some of GBRs top biotech entrepreneurs and UK-based pharmaceutical and biotech companies. Another great resource awarded through the competition is mentorship from McKinsey & Company. Oncolinx continues to work hard everyday to develop safer, more powerful cancer therapies.